Viveon Health Acquisition Corp.
Healthcare · Pharmaceutical Preparations · SEC filings ↗ · Compare ⊕
Financials
SEC XBRL · annual| FY22 | FY21 | FY20 | |
|---|---|---|---|
| Revenue | — | — | — |
| Operating income | −$2.4M | −$4.1M | −$450,472 |
| Net income | −$486,788 | $2.5M | −$2.2M |
| Total assets | $53.9M | $203.7M | $207.0M |
| Total liabilities | $50.6M | $13.4M | $19.4M |
| Equity | −$16.1M | −$13.0M | −$15.6M |
| EPS (diluted) | $-0.04 | $0.10 | — |
| Shares out. | 10.1M | 25.2M | 5.0M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2022- Operating margin
- —
- Net margin
- —
- Return on equity
- 3.0%
- Return on assets
- −0.9%
- Return on capital (ROCE)
- −18.2%
- Liabilities / assets
- 93.8%
- Debt / equity
- —
- Book value / share
- $-1.60
- Revenue growth (YoY)
- —
- Net income growth (YoY)
- −119.6%
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2022- Altman Z″ (distress)
- -6.57distress
- Accruals / assets
- 2.3%clean
- Piotroski F-Score
- 1/7weak
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast. What these scores mean →
Signs
● 3 severe● 2 warning● 1 good- Negative shareholder equity
- Altman Z″ in the distress zone
- Filed a late-filing notice (Form NT) — missed an SEC deadline
- High leverage (liabilities > 70% of assets)
- Negative operating cash flow
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Risk flags
late SEC filings- NT 10-Qmissed a reporting deadline ↗May 30, 2024
- NT 10-Kmissed a reporting deadline ↗Mar 29, 2024
- NT 10-Qmissed a reporting deadline ↗Nov 15, 2023
- NT 10-Qmissed a reporting deadline ↗Aug 14, 2023
- NT 10-Qmissed a reporting deadline ↗May 15, 2023
- NT 10-Kmissed a reporting deadline ↗Mar 31, 2023
A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.
Material events
SEC Form 8-K · most recent- Delisting / listing-standard noticeJul 19, 2024
- Entered a material agreement · New financial obligationJun 5, 2024
- Shareholder vote · Other material eventApr 1, 2024
- Entered a material agreementMar 27, 2024
- Delisting / listing-standard notice · Regulation FD disclosureFeb 27, 2024
- Prior financials not reliable (restatement)Jan 5, 2024
- Shareholder voteDec 29, 2023
- Delisting / listing-standard noticeDec 26, 2023
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗Event-driven situations (1)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.